Evidence map›Paper›PMID 26557873›Full record

ArticleEcancermedicalscience2015

Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience.

Ana Vaz da Conceição, Dora Bernardo, Lygia Vieira Lopes, Fernando Miguel, Fernanda Bessa, Fernando Monteiro, Cristina Santos, Blasques Oliveira, Lúcio Lara Santos

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana Vaz da ConceiçãoCancer Unit of Girassol Clinic, Comandante Gika 225, Luanda, Angola.
Dora BernardoPharmacy Department of Portuguese Institute of Oncology, Rua Dr António Bernardino de Almeida - 4200-072, Porto, Portugal.
Lygia Vieira LopesCancer Unit of Sagrada Esperança Clinic, Av Murtala Mohammed, Luanda, Angola.
Fernando MiguelAngolan Institute of Cancer Control, Rua Amilcar Cabral, Luanda, Angola.
Fernanda BessaPharmacy Department of Portuguese Institute of Oncology, Rua Dr António Bernardino de Almeida - 4200-072, Porto, Portugal.
Fernando MonteiroNurse Department of Portuguese Institute of Oncology, Rua Dr António Bernardino de Almeida - 4200-072, Porto, Portugal.
Cristina SantosONCOCIR - Education and Care in Oncology, Marçal, Luanda, Angola.
Blasques OliveiraONCOCIR - Education and Care in Oncology, Marçal, Luanda, Angola.
Lúcio Lara SantosONCOCIR - Education and Care in Oncology, Marçal, Luanda, Angola ; Experimental Pathology and Therapeutics Group and Surgical Oncology Department, Portuguese Institute of Oncology, Rua Dr António Bernardino de Almeida - 4200-072, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In African countries, higher rates of late-stage cancers at the time of first diagnosis are a reality. In this context, hazardous drugs (HDs), such as chemotherapy, play an important role and have immense benefits for patients' treatment. HDs should be handled under specific conditions. At least a class 5 environment primary engineering control (PEC), physically located in an appropriate buffer area, is mandatory for sterile HDs compounding, as well as administrative control, personal protective equipment, work practices and other engineering and environmental controls, in order to protect the environment, patient, and worker. The aim of this study is to describe the Angolan experience regarding the development of oncology pharmacy units and discuss international evidence-based guidelines on handling HDs and related waste. Measures to incorporate modern and economical solutions to upgrade or build adequate and safe facilities and staff training, in order to comply with international guidelines in this area, are crucial tasks for African countries of low and middle income.

Indexed as

Angolachemotherapyhazardous drugslow- and middle-income industriesoncology pharmacy units

Identifiers

PMID26557873
PMCPMC4631569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.